Hyaluronic acid/polyethylene glycol nanoparticles for controlled delivery of mitoxantrone

References

• Barar J, Kafil V, Majd MH, et al. Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells. J Nanobiotechnol. 2015;13:26.
   PubMed Web of Science ®Google Scholar
• Dores-Sousa JL, Duarte JA, Seabra V, et al. The age factor for mitoxantrone’s cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury. Toxicology. 2015;329:106–119.
   PubMed Web of Science ®Google Scholar
• Rossato LG, Costa VM, de Pinho PG, et al. The metabolic profile of mitoxantrone and its relation with mitoxantrone-induced cardiotoxicity. Arch Toxicol. 2013;87:1809–1820.
   PubMed Web of Science ®Google Scholar
• Heidari Majd M, Asgari D, Barar J, et al. Specific targeting of cancer cells by multifunctional mitoxantrone-conjugated magnetic nanoparticles. J Drug Target. 2013;21:328–340.
   PubMed Web of Science ®Google Scholar
• Liu Y, Sun J, Cao W, et al. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery. Int J Pharm. 2011;421:160–169.
   PubMed Web of Science ®Google Scholar
• Heidari Majd M, Akbarzadeh A, Sargazi A. Evaluation of host-guest system to enhance the tamoxifen efficiency. Artif Cells Nanomed Biotechnol. 2017;45:441–447.
   PubMed Web of Science ®Google Scholar
• Sargazi A, Majd MH. Different applications of magnetic nanoparticles in the rapid monitoring of ochratoxin A. Orient J Chem. 2017;33:346–354.
   Web of Science ®Google Scholar
• Sargazi A, Aliabadi A, Rahdari A, et al. A simple and fast method for magnetic solid phase extraction of ochratoxin A. J Braz Chem Soc. 2017;28:950–959.
   Web of Science ®Google Scholar
• Lin WJ, Lee W-C, Shieh M-J. Hyaluronic acid conjugated micelles possessing CD44 targeting potential for gene delivery. Carbohydr Polym. 2017;155:101–108.
   PubMed Web of Science ®Google Scholar
• Sargazi A, Kuhestani K, Nosrat Nahoki T, et al. Specific targeting of folate receptor by methotrexate conjugated modified magnetic nanoparticles: enzymatic release and cytotoxic study. Int J Pharm Sci Res. 2015;6:5047–5055.
   Web of Science ®Google Scholar
• Saei AA, Barzegari A, Majd MH, et al. Fe3O4 nanoparticles engineered for plasmid DNA delivery to Escherichia coli. J Nanopart Res. 2014;16:2521.
   Web of Science ®Google Scholar
• Banerji S, Wright AJ, Noble M, et al. Structures of the Cd44–hyaluronan complex provide insight into a fundamental carbohydrate-protein interaction. Nat Struct Mol Biol. 2007;14:234–239.
   PubMed Web of Science ®Google Scholar
• Yin H, Zhao F, Zhang D, et al. Hyaluronic acid conjugated β-cyclodextrin-oligoethylenimine star polymer for CD44-targeted gene delivery. Int J Pharm. 2015;483:169–179.
   PubMedGoogle Scholar
• Choi KY, Chung H, Min KH, et al. Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials. 2010;31:106–114.
   PubMed Web of Science ®Google Scholar
• Nguyen TT, Tran DP, Huy PDQ, et al. Ligand binding to anti-cancer target CD44 investigated by molecular simulations. J Mol Model. 2016;22:165.
   PubMed Web of Science ®Google Scholar
• Hiraga T, Nakamura H. Comparable roles of CD44v8-10 and CD44s in the development of bone metastases in a mouse model. Oncol Lett. 2016;12:2962–2969.
   PubMed Web of Science ®Google Scholar
• Qhattal HSS, Liu X. Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes. Mol Pharm. 2011;8:1233–1246.
   PubMed Web of Science ®Google Scholar
• Mansouri-Torshizi H, Rezaei E, Kamranfar F, et al. Investigating the apoptosis ability of ethylenediamine 8-hydroxyquinolinato palladium (II) complex. Adv Pharm Bull. 2016;6:449–453.
   PubMed Web of Science ®Google Scholar
• Shiri F, Shahraki S, Baneshi S, et al. Synthesis, characterization, in vitro cytotoxicity, in silico ADMET analysis and interaction studies of 5-dithiocarbamato-1,3,4-thiadiazole-2-thiol and its zinc(ii) complex with human serum albumin: combined spectroscopy and molecular docking investigations. RSC Adv. 2016;6:106516–106526.
   Web of Science ®Google Scholar
• Teriete P, Banerji S, Noble M, et al. Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44. Mol Cell. 2004;13:483–496.
   PubMed Web of Science ®Google Scholar
• Koes DR, Baumgartner MP, Camacho CJ. Lessons learned in empirical scoring with Smina from the CSAR 2011 benchmarking exercise. J Chem Inf Model. 2013;53:1893–1904.
   PubMed Web of Science ®Google Scholar
• Huey R, Morris GM, Olson AJ, et al. A semiempirical free energy force field with charge-based desolvation. J Comput Chem. 2007;28:1145–1152.
   PubMed Web of Science ®Google Scholar
• Jordan AR, Racine RR, Hennig MJP, et al. The role of CD44 in disease pathophysiology and targeted treatment. Front Immunol. 2015;6:182.
   PubMed Web of Science ®Google Scholar
• Lee H, Lee K, Park TG. Hyaluronic acid − paclitaxel conjugate micelles: synthesis, characterization, and antitumor activity. Bioconjug Chem. 2008;19:1319–1325.
   PubMed Web of Science ®Google Scholar
• An G, Morris ME. HPLC analysis of mitoxantrone in mouse plasma and tissues: application in a pharmacokinetic study. J Pharm Biomed Anal. 2010;51:750–753.
   PubMed Web of Science ®Google Scholar
• Johnson JL, Ahmad A, Khan S, et al. Improved liquid chromatographic method for mitoxantrone quantification in mouse plasma and tissues to study the pharmacokinetics of a liposome entrapped mitoxantrone formulation. J Chromatogr B: Analyt Technol Biomed Life Sci. 2004;799:149–155.
   PubMed Web of Science ®Google Scholar
• Heidari Majd M, Asgari D, Barar J, et al. Tamoxifen loaded folic acid armed PEGylated magnetic nanoparticles for targeted imaging and therapy of cancer. Colloids Surf B Biointerfaces. 2013;106:117–125.
   PubMed Web of Science ®Google Scholar
• Dhiman S, Mishra N, Sharma S. Development of PEGylated solid lipid nanoparticles of pentoxifylline for their beneficial pharmacological potential in pathological cardiac hypertrophy. Artif Cells Nanomed Biotechnol. 2016;44:1901–1908.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Zhang J, Cheng R, et al. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts. J Control Release. 2015;205:144–154.
   PubMed Web of Science ®Google Scholar
• Mindell JA. Lysosomal acidification mechanisms. Annu Rev Physiol. 2012;74:69–86.
   PubMed Web of Science ®Google Scholar
• Huang Y, Chu T, Liao T, et al. Downregulation of lysosomal and further gene expression characterization in lung cancer patients with bone metastasis. Artif Cells Nanomed Biotechnol. 2017;45:758–764.
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407:249–257.
   PubMed Web of Science ®Google Scholar
• Thomas RG, Moon MJ, Lee H, et al. Hyaluronic acid conjugated superparamagnetic iron oxide nanoparticle for cancer diagnosis and hyperthermia therapy. Carbohydr Polym. 2015;131:439–446.
   PubMed Web of Science ®Google Scholar
• Ramírez D, Caballero J. Is it reliable to use common molecular docking methods for comparing the binding affinities of enantiomer pairs for their protein target? IJMS. 2016;17:525.
   Google Scholar
• Oksuzoglu E, Ertan-Bolelli T, Can H, et al. Antitumor activities on HL-60 human leukemia cell line, molecular docking, and quantum-chemical calculations of some sulfonamide-benzoxazoles. Artif Cells Nanomed Biotechnol. 2016;1–9.
   PubMed Web of Science ®Google Scholar